Research Paper: The research on using a Tethered Agonist Approach to Map the Structure of the Receptor

Tether agonist method for mapping ion channel proteins - Structural model of agonist binding sites for nicotinic acetylcholine receptors Lintong Li, Wenge Zhong, Niki Zacharias, Caroline Gibbs, Henry A Lester, Dennis A. Dougherty. Condensation for research purposes: The purpose of this study was to develop a structural model of nicotinic acetylcholine receptors and to more easily understand the structure and function of membrane proteins using newer techniques.

LSD is a serotonergic receptor agonist, and most of the psychoactive effect of LSD is thought to be due to agonistic action of serotonin receptor in the brain midbrain (filter sensory stimulation). Although MDMA is structurally similar, it is more effective than mescaline and methamphetamine and stimulates the release of serotonin and dopamine from the CNS. Long-term use of MDMA can cause serotonin neurotoxicity, potentially leading to long-term loss of language and visual memory. PCP blocks the ion channel of glutamatergic NMDA receptors and prevents calcium ions from entering the dendrites of postsynaptic neurons and blocking synaptic excitement when glutamate binds to these receptors.

Cannabis contains two different types of molecules that interact with cannabinoid receptors. It is an agonist and an antagonist. An agonist is a drug that binds to the same receptor as a natural chemical and produces the same effect. A type of dopamine agonist used to treat Parkinson's disease. Agonists can enhance the activity of neurotransmitters (in this case, dopamine). Requip, Mirapex, Neupro, Apokyn are common dopamine agonists. It is not a chemical messenger regulating dopamine, exercise and mood (neurotransmitter), but it is associated with dopamine receptors. Antagonists are different because they adhere to the receptor but interfere with the action of natural chemicals. Medical cannabis can include cannabinoid agonists and antagonists. Recreation Use of marijuana arises from the influence on agonists

Sometimes drugs that can not be classified as pure agonists or pure antagonists have a role in their effect on its activation on the receptor but have been found to be such that it is not seen by agonists There. These are called partial agonists. It seems strange that agonists can only function "partially", so there are many theories about how these work. One such explanation is that when a partial agonist binds to a binding site it forms the desired interaction and causes a conformational change but this change is not exactly the same as a pure agonist so that the channel It is possible to activate only partly, for example because ion channels are only partially opened (Patrick, 2005). Another theory involves partial agonists being able to bind to receptors in more than one place, thus one binding method produces an agonist effect and the other produces antagonism.